- Community-Beiträge
- Aktuellste Threads
| Geld/Brief | 728,40 $ / 1.120,94 $ |
| Spread | +53,89% |
| Schluss Vortag | 925,70 $ |
| Gehandelte Stücke | 51.421 |
| Tagesvolumen Vortag | 18.267.795 $ |
| Tagestief 926,02 $ Tageshoch 948,67 $ | |
| 52W-Tief 662,36 $ 52W-Hoch 1.072,71 $ | |
| Jahrestief 662,36 $ Jahreshoch 1.072,71 $ | |
| Umsatz in Mio. | 4.153 $ |
| Operatives Ergebnis (EBIT) in Mio. | 1.283 $ |
| Jahresüberschuss in Mio. | 1.292 $ |
| Umsatz je Aktie | 62,74 $ |
| Gewinn je Aktie | 19,52 $ |
| Gewinnrendite | +31,11% |
| Umsatzrendite | +31,11% |
| Return on Investment | +14,88% |
| Marktkapitalisierung in Mio. | 60.373 $ |
| KGV (Kurs/Gewinn) | 35,86 |
| KBV (Kurs/Buchwert) | 6,33 |
| KUV (Kurs/Umsatz) | 11,16 |
| Eigenkapitalrendite | +17,64% |
| Eigenkapitalquote | +84,34% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| Düsseldorf | 840,00 € | -1,18% | 850,00 € | 20.11.26 | |
| Frankfurt | 810,00 € | -1,82% | 825,00 € | 20.11.26 | |
| Gettex | 855,00 € | 0 % | 855,00 € | 20.11.26 | |
| Hamburg | 850,00 € | 0 % | 850,00 € | 20.11.26 | |
| Hannover | 850,00 € | 0 % | 850,00 € | 20.11.26 | |
| L&S RT | 845,00 € | 0 % | 845,00 € | 13:03 | |
| München | 860,00 € | -1,15% | 870,00 € | 20.11.26 | |
| Nasdaq | 926,10 $ | +0,04% | 925,70 $ | 20.11.26 | |
| NYSE | 927,16 $ | -1,74% | 943,57 $ | 20.11.26 | |
| NYSE American | 937,72 $ | -0,35% | 941,00 $ | 20.11.26 | |
| Quotrix | 860,00 € | 0 % | 860,00 € | 20.11.26 | |
| Stuttgart | 840,00 € | -1,75% | 855,00 € | 20.11.26 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 20.11.26 | 926,10 | 18,3 M |
| 19.11.26 | 942,04 | 31,2 M |
| 18.11.26 | 941,25 | 20,5 M |
| 17.11.26 | 947,52 | 77,8 M |
| 16.11.26 | 950,74 | 25,1 M |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 960,04 $ | -3,54% |
| 1 Monat | 869,72 $ | +6,48% |
| 6 Monate | 804,25 $ | +15,15% |
| 1 Jahr | 918,65 $ | +0,81% |
| 5 Jahre | 283,97 $ | +226,13% |
| Marktkapitalisierung | 60,37 Mrd. $ |
| Streubesitz | 53,58% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | ADR |
| +8,32% | FMR Inc |
| +4,26% | T. Rowe Price Associates, Inc. |
| +3,93% | Jupiter Topco LLC |
| +3,50% | Capital World Investors |
| +2,40% | Artisan Partners Limited Partnership |
| +1,59% | venBio Select Advisor LLC |
| +1,51% | American Funds EUPAC A |
| +1,48% | Wellington Management Company LLP |
| +1,25% | American Funds New Economy A |
| +1,24% | BlackRock Inc |
| +1,13% | RTW INVESTMENTS, LLC |
| +1,02% | Morgan Stanley - Brokerage Accounts |
| +0,97% | Fidelity Growth Company Fund |
| +0,79% | Janus Henderson Forty S |
| +0,75% | Fidelity OTC |
| +0,71% | Amvescap Plc. |
| +0,69% | iShares Biotechnology ETF |
| +0,64% | Bank of America Corp |
| +0,63% | AllianceBernstein L.P. |
| +0,49% | Janus Henderson Enterprise D |
| +0,48% | Bellevue Group AG |
| +0,47% | Sands Capital Management, LLC |
| +0,44% | Fidelity Contrafund |
| +0,43% | Bessemer Group Inc |
| +0,42% | William Blair Investment Management, LLC |
| +0,41% | SEI Investments Co |
| +0,4% | ClearBridge Advisors, LLC |
| +0,36% | Jennison Associates LLC |
| +0,33% | T. Rowe Price Growth Stock |
| +0,33% | Fidelity Puritan |
| +0,28% | T. Rowe Price Lrg Cp Gr I |
| +0,27% | Fidelity Growth Company K6 |
| +0,26% | Fidelity Advisor Growth Opps M |
| +0,25% | T. Rowe Price New Horizons |
| +0,24% | Fidelity Select Health Care |
| +0,24% | BGF World Healthscience A2 |
| +0,23% | Janus Henderson Global Life Sciences D |
| +0,23% | T. Rowe Price Overseas Stock |
| +0,23% | Artisan Mid Cap Investor |
| +0,23% | Janus Henderson Contrarian D |
| +46,378% | Institutionelle Aktionäre |
| +0,041% | Insider Aktionäre |
| +53,581% | Streubesitz |
FDA akzeptiert sBLA für VYVGART Hytrulo bei chronisch entzündlicher demyelinisierender Polyneuropathie
PDUFA 06/21/24
Pemphigus Studie floppt
https://www.n-tv.de/wirtschaft/der_boersen_tag/Biotechfirma-Argenx-verliert-sieben-Milliarden-Euro-Marktwert-article24613942.html